Should I obtain an abdominal aortic ultrasound to screen for an abdominal aortic aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Abdominal Aortic Aneurysm Screening Recommendations

If you are a man aged 65-75 who currently smokes or has ever smoked (≥100 cigarettes lifetime), you should obtain a one-time abdominal aortic ultrasound screening—this can reduce your risk of dying from AAA rupture by approximately 50%. 1

Screening Recommendations by Patient Category

Men Ages 65-75 Who Smoke or Have Ever Smoked (Grade B Recommendation)

  • Obtain one-time ultrasound screening 1
  • This population has the highest AAA prevalence and derives the greatest mortality benefit from screening 1
  • Evidence shows 42% reduction in AAA-related mortality (number needed to screen = 212) and 38% reduction in rupture rate (number needed to screen = 200) over 13-15 years of follow-up 2
  • Ultrasound screening has near 100% sensitivity and specificity for detecting AAA 3, 4

Men Ages 65-75 Who Have Never Smoked (Grade C Recommendation)

  • Screening may be selectively offered based on individual risk factors 1
  • AAA is much less common in this group, so most men will not benefit from screening 1
  • Consider screening if additional risk factors present: family history of AAA, hypertension, or other cardiovascular disease 5
  • The benefit is small but present in this population 1

Women Ages 65-75 Who Smoke or Have Ever Smoked (I Statement)

  • Insufficient evidence to recommend for or against routine screening 1
  • The Chichester trial found no significant mortality benefit in women over 10 years of follow-up (RR 0.88,95% CI 0.72-1.07) 2
  • AAA is uncommon in women who smoke compared to men 1
  • Individual screening decisions should weigh family history and other risk factors 5

Women Who Have Never Smoked (Grade D Recommendation)

  • Do not obtain routine screening 1
  • AAA is extremely rare in women who have never smoked 1
  • Screening has more potential harms than benefits in this population 1

Additional High-Risk Populations to Consider

Beyond the USPSTF guidelines, consider screening in:

  • Individuals over age 50 (either sex) with family history of AAA, regardless of smoking status 6
  • Hypertensive males aged 65-75 who are current or former smokers show 8% AAA prevalence in primary care screening 6

Screening Method

  • Duplex ultrasound is the recommended screening modality 3, 4, 5
  • Safe, painless, portable, and cost-effective 3
  • Measures maximum aortic diameter from outer wall to outer wall 3
  • No repeat screening needed if initial results are negative 4

Post-Screening Management

If AAA detected:

  • <5.5 cm diameter: Surveillance with periodic ultrasound imaging 1, 4
  • ≥5.5 cm diameter or rapidly growing: Consider elective surgical repair (open or endovascular) 1, 4

Important Caveats

  • Screening increases the total number of AAA-related procedures by 2.16 times compared to no screening over 13-15 years 2
  • Operative mortality for elective AAA repair ranges from 2-6% 7
  • Evidence suggests potential overdiagnosis of 45% among screen-detected men 2
  • Women have higher surgical mortality risk than men for AAA repair 1
  • Most AAAs remain asymptomatic until rupture, which has poor prognosis 1, 4

References

Guideline

acr appropriateness criteria® screening for abdominal aortic aneurysm.

Journal of the American College of Radiology, 2024

Research

Ultrasonographic screening for abdominal aortic aneurysms.

Annals of internal medicine, 2003

Research

Ultrasound screening for abdominal aortic aneurysm in primary care.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.